Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | mRNA-2416 |
Synonyms | |
Therapy Description |
mRNA-2416 is a lipid nanoparticle-encapsulated mRNA encoding the ligand, TNFSF4 (OX40L, CD252), which upon translation binds to TNFRSF4 (OX40, CD134) expressed on T-lymphocytes, potentially leading to proliferation of T-cells and enhanced anti-tumor response (Cancer Res 2020;80(16 Suppl):Abstract nr CT032, NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
mRNA-2416 | mRNA 2416 | mRNA-2416 is a lipid nanoparticle-encapsulated mRNA encoding the ligand, TNFSF4 (OX40L, CD252), which upon translation binds to TNFRSF4 (OX40, CD134) expressed on T-lymphocytes, potentially leading to proliferation of T-cells and enhanced anti-tumor response (Cancer Res 2020;80(16 Suppl):Abstract nr CT032, NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03323398 | Phase I | mRNA-2416 | Dose Escalation Study of mRNA 2416 for Intratumoral Injection to Patients With Advanced Malignancies | Terminated | USA | 0 |